US Stock MarketDetailed Quotes

MBX MBX Biosciences

Watchlist
  • 9.870
  • +0.520+5.56%
Close Apr 29 16:00 ET
329.90MMarket Cap-5.33P/E (TTM)

About MBX Biosciences Company

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.

Company Profile

SymbolMBX
Company NameMBX Biosciences
Listing DateSep 13, 2024
Issue Price16.00
Founded2018
CEOMr. Peter Kent Hawryluk
MarketNASDAQ
Employees43
Fiscal Year Ends12-31
Address11711 North Meridian Street,Suite 300
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-317-659-0200

Company Executives

  • Name
  • Position
  • Salary
  • Peter Kent Hawryluk
  • President, Chief Executive Officer and Director
  • 2.24M
  • Richard B. Bartram
  • Chief Financial Officer and Principal Accounting Officer
  • 1.15M
  • Dr. Salomon Azoulay, M.D.
  • Chief Medical Officer
  • 3.10M
  • Stephen L. Hoerter
  • Independent Director
  • --
  • Steven L. Hoerter
  • Independent Director
  • --
  • Patrick J. Heron
  • Lead Independent Director
  • 213.31K
  • James M. Cornelius
  • Independent Director
  • 366.73K
  • Edward T. Mathers
  • Independent Director
  • 205.75K
  • Dr. Tiba Aynechi, PhD
  • Independent Director
  • 207.06K
  • Dr. Steven Ryder, M.D.
  • Independent Director
  • 478.96K
  • Dr. Ora H. Pescovitz, M.D.
  • Independent Director
  • 422.26K
  • Dr. Carl L. Gordon, C.F.A.,PhD
  • Independent Director
  • 206.77K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More